Darunavir

BreastfeedingPediatric
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Abacavir, Alfuzosin, Almotriptan, Alosetron, Alprazolam, Amiodarone, Antifungals, Apixaban, Artemether/Lumefantrine, Astemizole, Atorvastatin, Bortezomib, Brinzolamide, Calcium channel blockers, Captopril, Carbamazepine, Ciclesonide, Cisapride, Clarithromycin, Colchicine, Conivaptan, Cyclosporine, CYP2D6 substrates, CYP3A4 inhibitors, inducers and substrates, Dabigatran, Dasatinib, Deferasirox, Delavirdine, Didanosine, Dienogest, Digoxin, Dihydroergotamine, Dronedarone, Duloxetine, Dutasteride, Efavirenz, Elbasvir & Grazoprevir, Enfuvirtide, Eplerenone, Ergotamine, Estrogens, Etravirine, Everolimus, Fentanyl, Fesoterodine, Food, Fusidic Acid, Glecaprevir & Pibrentasvir, Guanfacine, Halofantrine, HMG-CoA reductase inhibitors, Indinavir, Inhaled corticosteroids, Ixabepilone, Ketoconazole, Lidocaine, Lopinavir, Lovastatin, Maraviroc, Meperidine, Methadone, Methylprednisolone, Midazolam, Mifepristone, Mometasone, Nefazodone, Nilotinib, Nisoldipine, Olaparib, P-glycoprotein substrates, Paricalcitol, Paroxetine Hydrochloride, Pazopanib, Phenobarbital, Phenytoin, Pimecrolimus, Pimozide, Prasugrel, Pravastatin, Protease inhibitors, Quetiapine, Quinidine, Quinine, Ranolazine, Rifabutin, Rifampin, Rilpivirine, Rivaroxaban, Romidepsin, Rosuvastatin, Salmeterol, Saquinavir, Saxagliptin, Sertraline, Sildenafil, Silodosin, Simeprevir, Simvastatin, Sirolimus, Sorafenib, St John's Wort, Tacrolimus, Tadalafil, Tamsulosin, Telaprevir, Temsirolimus, Tenofovir Disoproxil, Terfenadine, Theophylline, Tolvaptan, Topotecan, Trazodone, Triazolam, Tricyclic antidepressants, Vardenafil, Viloxazine, Voriconazole, Warfarin, Zidovudine

PREGNANCY CATEGORY: C

Investigated for treating COVID-19.

Darunavir is a sulfonamide and can be absorbed systemically. Sulfonamides can produce severe, possibly fatal, reactions such as toxic epidermal necrolysis and Stevens-Johnson syndrome.

Prezcobix is darunavir and cobicistat.

Our database has 35 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
RENAL.
OTHER.


Page last updated 07/31/2023

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top